USD 0.09
(10.97%)
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2024 | 11.78 Million USD | -10.8% |
2023 | 13.2 Million USD | -3.85% |
2022 | 13.73 Million USD | 0.8% |
2021 | 13.62 Million USD | 77.44% |
2020 | 7.67 Million USD | -59.32% |
2019 | 18.87 Million USD | -8.71% |
2018 | 20.67 Million USD | 50.49% |
2017 | 13.73 Million USD | 41.87% |
2016 | 9.68 Million USD | -18.24% |
2015 | 11.84 Million USD | 42.95% |
2014 | 8.28 Million USD | -6.85% |
2013 | 8.89 Million USD | -1.21% |
2012 | 9 Million USD | 9.76% |
2011 | 8.2 Million USD | -1.05% |
2010 | 8.29 Million USD | -22.28% |
2009 | 10.66 Million USD | -12.29% |
2008 | 12.16 Million USD | 62.23% |
2007 | 7.49 Million USD | 54.49% |
2006 | 4.85 Million USD | 22.97% |
2005 | 3.94 Million USD | -29.49% |
2004 | 5.59 Million USD | 9.48% |
2003 | 5.11 Million USD | 3.65% |
2002 | 4.93 Million USD | -22.13% |
2001 | 6.33 Million USD | 8.99% |
2000 | 5.81 Million USD | -18.16% |
1999 | 7.1 Million USD | 20.34% |
1998 | 5.9 Million USD | 28.26% |
1997 | 4.6 Million USD | 12.2% |
1996 | 4.1 Million USD | 41.38% |
1995 | 2.9 Million USD | -12.12% |
1994 | 3.3 Million USD | 57.14% |
1993 | 2.1 Million USD | 162.5% |
1992 | 800 Thousand USD | 33.33% |
1991 | 600 Thousand USD | 0.0% |
1990 | 600 Thousand USD | -62.5% |
1989 | 1.6 Million USD | 0.0% |
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2024 Q4 | 11.78 Million USD | -8.82% |
2024 Q1 | 13.8 Million USD | 4.51% |
2024 Q3 | 12.91 Million USD | -6.17% |
2024 Q2 | 13.76 Million USD | -0.24% |
2023 FY | 13.2 Million USD | -3.85% |
2023 Q1 | 13.72 Million USD | -0.05% |
2023 Q4 | 13.2 Million USD | -7.16% |
2023 Q3 | 14.22 Million USD | -2.23% |
2023 Q2 | 14.54 Million USD | 5.97% |
2022 Q1 | 13.35 Million USD | -1.99% |
2022 Q3 | 14.26 Million USD | 9.7% |
2022 Q2 | 13 Million USD | -2.61% |
2022 FY | 13.73 Million USD | 0.8% |
2022 Q4 | 13.73 Million USD | -3.74% |
2021 Q2 | 18.61 Million USD | 8.29% |
2021 FY | 13.62 Million USD | 77.44% |
2021 Q1 | 17.18 Million USD | 123.83% |
2021 Q3 | 17.36 Million USD | -6.72% |
2021 Q4 | 13.62 Million USD | -21.52% |
2020 Q2 | 21.09 Million USD | -1.71% |
2020 Q1 | 21.45 Million USD | 13.68% |
2020 Q3 | 22.18 Million USD | 5.18% |
2020 Q4 | 7.67 Million USD | -65.39% |
2020 FY | 7.67 Million USD | -59.32% |
2019 Q3 | 18.42 Million USD | 6.48% |
2019 Q4 | 18.87 Million USD | 2.47% |
2019 FY | 18.87 Million USD | -8.71% |
2019 Q1 | 19.29 Million USD | -6.68% |
2019 Q2 | 17.3 Million USD | -10.34% |
2018 Q4 | 20.67 Million USD | -3.45% |
2018 FY | 20.67 Million USD | 50.49% |
2018 Q1 | 19.15 Million USD | 39.4% |
2018 Q3 | 21.41 Million USD | -4.47% |
2018 Q2 | 22.41 Million USD | 17.05% |
2017 Q4 | 13.73 Million USD | 14.49% |
2017 FY | 13.73 Million USD | 41.87% |
2017 Q1 | 9.93 Million USD | 2.55% |
2017 Q2 | 10.12 Million USD | 1.9% |
2017 Q3 | 12 Million USD | 18.58% |
2016 Q4 | 9.68 Million USD | 8.11% |
2016 FY | 9.68 Million USD | -18.24% |
2016 Q3 | 8.95 Million USD | -9.11% |
2016 Q2 | 9.85 Million USD | -1.31% |
2016 Q1 | 9.98 Million USD | -15.69% |
2015 Q3 | 12.24 Million USD | 4.41% |
2015 Q1 | 12.2 Million USD | 47.33% |
2015 Q2 | 11.72 Million USD | -3.95% |
2015 FY | 11.84 Million USD | 42.95% |
2015 Q4 | 11.84 Million USD | -3.25% |
2014 Q1 | 8.78 Million USD | -1.29% |
2014 Q4 | 8.28 Million USD | -1.07% |
2014 Q2 | 8.95 Million USD | 1.97% |
2014 Q3 | 8.37 Million USD | -6.45% |
2014 FY | 8.28 Million USD | -6.85% |
2013 Q2 | 8.96 Million USD | -0.38% |
2013 Q4 | 8.89 Million USD | 2.64% |
2013 Q3 | 8.66 Million USD | -3.31% |
2013 FY | 8.89 Million USD | -1.21% |
2013 Q1 | 8.99 Million USD | -0.07% |
2012 Q1 | 8.87 Million USD | 8.23% |
2012 Q3 | 9.17 Million USD | 5.6% |
2012 FY | 9 Million USD | 9.76% |
2012 Q4 | 9 Million USD | -1.88% |
2012 Q2 | 8.68 Million USD | -2.13% |
2011 FY | 8.2 Million USD | -1.05% |
2011 Q4 | 8.2 Million USD | 1.35% |
2011 Q3 | 8.09 Million USD | 0.31% |
2011 Q2 | 8.06 Million USD | -1.78% |
2011 Q1 | 8.21 Million USD | -0.9% |
2010 Q1 | 10.91 Million USD | 2.35% |
2010 FY | 8.29 Million USD | -22.28% |
2010 Q4 | 8.29 Million USD | -16.14% |
2010 Q3 | 9.88 Million USD | 0.73% |
2010 Q2 | 9.81 Million USD | -10.11% |
2009 FY | 10.66 Million USD | -12.29% |
2009 Q1 | 12.54 Million USD | 3.18% |
2009 Q4 | 10.66 Million USD | -4.63% |
2009 Q2 | 13.13 Million USD | 4.64% |
2009 Q3 | 11.18 Million USD | -14.81% |
2008 Q2 | 12.53 Million USD | 9.88% |
2008 Q3 | 12.98 Million USD | 3.62% |
2008 FY | 12.16 Million USD | 62.23% |
2008 Q4 | 12.16 Million USD | -6.33% |
2008 Q1 | 11.4 Million USD | 52.12% |
2007 Q1 | 5.04 Million USD | 3.95% |
2007 FY | 7.49 Million USD | 54.49% |
2007 Q4 | 7.49 Million USD | 40.87% |
2007 Q3 | 5.32 Million USD | 9.66% |
2007 Q2 | 4.85 Million USD | -3.8% |
2006 FY | 4.85 Million USD | 22.97% |
2006 Q1 | 4.06 Million USD | 3.06% |
2006 Q2 | 4.63 Million USD | 14.03% |
2006 Q3 | 5.49 Million USD | 18.55% |
2006 Q4 | 4.85 Million USD | -11.73% |
2005 Q4 | 3.94 Million USD | -15.41% |
2005 FY | 3.94 Million USD | -29.49% |
2005 Q1 | 5.35 Million USD | -4.35% |
2005 Q2 | 4.93 Million USD | -7.74% |
2005 Q3 | 4.66 Million USD | -5.54% |
2004 Q3 | 5.88 Million USD | 3.44% |
2004 Q2 | 5.68 Million USD | 0.23% |
2004 Q1 | 5.67 Million USD | 10.96% |
2004 Q4 | 5.59 Million USD | -4.83% |
2004 FY | 5.59 Million USD | 9.48% |
2003 FY | 5.11 Million USD | 3.65% |
2003 Q1 | 5.14 Million USD | 4.37% |
2003 Q3 | 5.16 Million USD | 4.48% |
2003 Q2 | 4.94 Million USD | -3.95% |
2003 Q4 | 5.11 Million USD | -1.05% |
2002 Q2 | 6.38 Million USD | -8.49% |
2002 FY | 4.93 Million USD | -22.13% |
2002 Q4 | 4.93 Million USD | -17.46% |
2002 Q3 | 5.97 Million USD | -6.4% |
2002 Q1 | 6.97 Million USD | 10.14% |
2001 Q3 | 6.19 Million USD | 14.25% |
2001 FY | 6.33 Million USD | 8.99% |
2001 Q1 | 5.76 Million USD | -0.85% |
2001 Q2 | 5.42 Million USD | -5.86% |
2001 Q4 | 6.33 Million USD | 2.22% |
2000 FY | 5.81 Million USD | -18.16% |
2000 Q2 | 6.7 Million USD | -2.9% |
2000 Q3 | 6.37 Million USD | -4.9% |
2000 Q4 | 5.81 Million USD | -8.8% |
2000 Q1 | 6.9 Million USD | -2.82% |
1999 Q1 | 8.1 Million USD | 37.29% |
1999 Q3 | 7.1 Million USD | -2.74% |
1999 Q4 | 7.1 Million USD | 0.0% |
1999 Q2 | 7.3 Million USD | -9.88% |
1999 FY | 7.1 Million USD | 20.34% |
1998 Q2 | 4.7 Million USD | 9.3% |
1998 Q3 | 5.2 Million USD | 10.64% |
1998 Q4 | 5.9 Million USD | 13.46% |
1998 FY | 5.9 Million USD | 28.26% |
1998 Q1 | 4.3 Million USD | -6.52% |
1997 Q2 | 3.7 Million USD | -9.76% |
1997 Q4 | 4.6 Million USD | 15.0% |
1997 FY | 4.6 Million USD | 12.2% |
1997 Q1 | 4.1 Million USD | 0.0% |
1997 Q3 | 4 Million USD | 8.11% |
1996 Q3 | 3 Million USD | 0.0% |
1996 FY | 4.1 Million USD | 41.38% |
1996 Q1 | 2.9 Million USD | 0.0% |
1996 Q2 | 3 Million USD | 3.45% |
1996 Q4 | 4.1 Million USD | 36.67% |
1995 Q1 | 3.2 Million USD | -3.03% |
1995 FY | 2.9 Million USD | -12.12% |
1995 Q4 | 2.9 Million USD | -3.33% |
1995 Q3 | 3 Million USD | 0.0% |
1995 Q2 | 3 Million USD | -6.25% |
1994 Q3 | 3.1 Million USD | -6.06% |
1994 Q1 | 3 Million USD | 42.86% |
1994 Q2 | 3.3 Million USD | 10.0% |
1994 Q4 | 3.3 Million USD | 6.45% |
1994 FY | 3.3 Million USD | 57.14% |
1993 FY | 2.1 Million USD | 162.5% |
1993 Q3 | 1.7 Million USD | 88.89% |
1993 Q1 | 500 Thousand USD | -37.5% |
1993 Q2 | 900 Thousand USD | 80.0% |
1993 Q4 | 2.1 Million USD | 23.53% |
1992 Q4 | 800 Thousand USD | 0.0% |
1992 Q2 | 500 Thousand USD | 0.0% |
1992 FY | 800 Thousand USD | 33.33% |
1992 Q1 | 500 Thousand USD | -16.67% |
1992 Q3 | 800 Thousand USD | 60.0% |
1991 FY | 600 Thousand USD | 0.0% |
1991 Q2 | 500 Thousand USD | -16.67% |
1991 Q1 | 600 Thousand USD | 0.0% |
1991 Q3 | 700 Thousand USD | 40.0% |
1991 Q4 | 600 Thousand USD | -14.29% |
1990 Q3 | 800 Thousand USD | 0.0% |
1990 FY | 600 Thousand USD | -62.5% |
1990 Q4 | 600 Thousand USD | -25.0% |
1989 Q4 | 1.6 Million USD | 0.0% |
1989 FY | 1.6 Million USD | 0.0% |
Name | Total Liabilities | Total Liabilities Difference |
---|---|---|
Acutus Medical, Inc. | 54.83 Million USD | 78.519% |
Biotricity, Inc. | 35.91 Million USD | 67.204% |
Cell MedX Corp. | 872.57 Thousand USD | -1250.037% |
Nemaura Medical Inc. | 26.37 Million USD | 55.34% |
PetVivo Holdings, Inc. | 2.42 Million USD | -384.918% |
RetinalGenix Technologies Inc. | 1.4 Million USD | -737.957% |
Sonendo, Inc. | 49.74 Million USD | 76.317% |
Telesis Bio, Inc. | 40.87 Million USD | 71.179% |
Talis Biomedical Corporation | 29.22 Million USD | 59.69% |
Viveve Medical, Inc. | 10.84 Million USD | -8.603% |